Sign inJoin waitlistJoin the waitlist

Ericka Greene

Director, Neuromuscular and Myotonic Dystrophy Clinics · Houston Methodist Hospital

Credentials: · · · · ·

History

New York Presbyterian Hospital
Present

Neuromuscular Medicine
Baylor College of Medicine
1999–2000
Neurology
Baylor College of Medicine
1995–1999
McGovern Medical School
1991–1995

Research

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Science · 2015 · 797 citations
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
The Lancet Neurology · 2013 · 498 citations
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue
Annals of Neurology · 2004 · 449 citations

Stanley Appel
31 papers
JK
Jonathan Katz
9 papers
Jonathan Glass
8 papers
Merit Cudkowicz
8 papers
Jeffrey Statland
7 papers
AP
Alan Pestronk
6 papers
NJ
Nicholas Johnson
6 papers
WD
William David
6 papers
Andrea Swenson
5 papers
Charles Thornton
5 papers
Hiroshi Mitsumoto
5 papers
Jeffrey Rosenfeld
5 papers

Clinical trials

Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Principal investigator · Completed · Phase 3
Santhera Pharmaceuticals
2009–2014
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
Study director · Completed
The Methodist Hospital Research Institute
2008–2011
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2033